Natera (NTRA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Executive Chairman welcomed attendees and outlined the agenda, including formal matters and voting procedures.
Independent accountants and outside counsel were present for oversight.
Board and executive committee updates
Election held for three Class II directors for a three-year term and one Class I director for a two-year term.
Board unanimously recommended all director nominees.
Shareholder proposals
Five proposals were presented: election of directors, ratification of auditors, advisory vote on executive compensation, advisory vote on frequency of compensation votes, and amendment to the equity incentive plan.
Board unanimously recommended approval of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Natera
- Record Q1, robust clinical data, and new launches drive growth and future expansion.NTRA
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Q1 2026 revenue up 39% to $697M, record test volumes, margin gains, and raised guidance.NTRA
Q1 202611 May 2026 - Proxy seeks approval for director elections, auditor, compensation, and equity plan amid strong growth.NTRA
Proxy filing23 Apr 2026 - Key votes include director elections, auditor ratification, and equity plan amendment.NTRA
Proxy filing23 Apr 2026 - Record Q4 revenue and margin gains, with strong 2026 growth and cash flow outlook.NTRA
Q4 20258 Apr 2026 - Signatera's growth accelerates with robust data, expanding coverage, and key FDA milestones ahead.NTRA
Leerink Global Healthcare Conference 202611 Mar 2026 - Record growth, expanding coverage, and aggressive R&D drive strong financial and market momentum.NTRA
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Q2 revenue up 58% to $413.4M, gross margin 58.8%, guidance raised for FY2024.NTRA
Q2 20242 Feb 2026 - Strong Q2 growth, margin gains, and product innovation set up continued momentum into 2025.NTRA
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026